Back to full portfolio

Superfluid DX

Novel diagnostic platform using cell-free mRNA to diagnose neuro-degenerative and other diseases.
WEBSITE
Founder(s)
Dr. Stephen Quake, Scripps Institute
SECTOR(S)
Healthcare
Investment Stage
Early
Status
Private
Superfluid DXPlay Icon

More about Superfluid DX

Perspectives

Superfluid Dx - Leveraging cf-mRNA for early disease detection

Read more

Superfluid Dx - Leveraging cf-mRNA for early disease detection

Read more
Perspectives

WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx

Read more
PR Newswire

WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx

Read more